» Articles » PMID: 2998522

Evidence for an A2-subtype Adenosine Receptor on Pancreatic Glucagon Secreting Cells

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1985 Nov 1
PMID 2998522
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of a 5'-substituted analogue of adenosine, 5'-N-ethylcarboxamidoadenosine (NECA) have been studied on glucagon secretion in vitro, using the isolated pancreas of the rat perfused in the presence of glucose (2.8 mM). NECA provoked a peak of glucagon secretion, the kinetics of which were comparable to those previously obtained with adenosine. The effect was concentration-dependent and appeared at nanomolar concentrations. The EC50 was approximately 4 X 10(-8) M. A comparison of relative potency between adenosine and NECA showed that NECA was about 800 fold more potent than adenosine in inducing glucagon secretion. Theophylline (50 microM) considerably decreased the peak of glucagon secretion induced by 1.65 microM NECA and totally suppressed the effect of 16.5 nM NECA. These results indicate the involvement of an adenosine receptor. These and other previous results (low stereoselectivity of N6-phenylisopropyladenosine) provide evidence for an adenosine receptor of the A2-subtype being involved in glucagon secretion.

Citing Articles

Glucose control of glucagon secretion-'There's a brand-new gimmick every year'.

Gylfe E Ups J Med Sci. 2016; 121(2):120-32.

PMID: 27044660 PMC: 4900067. DOI: 10.3109/03009734.2016.1154905.


Roux-en Y gastric bypass surgery induces genome-wide promoter-specific changes in DNA methylation in whole blood of obese patients.

Nilsson E, Ernst B, Voisin S, Almen M, Benedict C, Mwinyi J PLoS One. 2015; 10(2):e0115186.

PMID: 25710379 PMC: 4340013. DOI: 10.1371/journal.pone.0115186.


Regulatory role of adenosine in insulin secretion from pancreatic β-cells--action via adenosine A₁ receptor and beyond.

Szkudelski T, Szkudelska K J Physiol Biochem. 2014; 71(1):133-40.

PMID: 25432862 DOI: 10.1007/s13105-014-0371-y.


Purinergic signalling in endocrine organs.

Burnstock G Purinergic Signal. 2013; 10(1):189-231.

PMID: 24265070 PMC: 3944044. DOI: 10.1007/s11302-013-9396-x.


Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetes.

Yip L, Taylor C, Whiting C, Fathman C Diabetes. 2013; 62(12):4208-19.

PMID: 24264405 PMC: 3837064. DOI: 10.2337/db13-0614.


References
1.
LOUBATIERES A, Mariani M, Ribes G, De Malbosc H, CHAPAL J . [Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide]. Diabetologia. 1969; 5(1):1-10. DOI: 10.1007/BF01212212. View

2.
CHAPAL J, Roye M, Petit P . [Study of stereoisomers of N6-phenylisopropyladenosine on the secretion of pancreatic glucagon]. C R Seances Soc Biol Fil. 1985; 179(2):230-4. View

3.
Schutz W, Raberger G, KRAUPP O . Influence of aminophylline or beta-adrenoceptor blockade on glucagon release by a vasoactive adenosine analogue. Arch Int Pharmacodyn Ther. 1978; 234(2):214-20. View

4.
Schutz W, Raberger G, KRAUPP O . Evidence for glucagon-releasing activity of vasoactive adenosine analogues in the conscious dog. Naunyn Schmiedebergs Arch Pharmacol. 1978; 304(3):249-54. DOI: 10.1007/BF00507965. View

5.
Schutz W, Raberger G, BRUGGER G, KRAUPP O . Effect of a 5'-substituted adenosine analogue (744c96) on insulin and glucagon release in isolated rat islets of Langerhans. Arch Int Pharmacodyn Ther. 1979; 237(1):88-97. View